Myosin regulatory light chain 2, ventricular/cardiac muscle isoform
Also known as: MLC2, MYL2
Function
Contractile protein that plays a role in heart development and function. Following phosphorylation, plays a role in cross-bridge cycling kinetics and cardiac muscle contraction by increasing myosin lever arm stiffness and promoting myosin head diffusion; as a consequence of the increase in maximum contraction force and calcium sensitivity of contraction force. These events altogether slow down myosin kinetics and prolong duty cycle resulting in accumulated myosins being cooperatively recruited to actin binding sites to sustain thin filament activation as a means to fine-tune myofilament calcium sensitivity to force (By similarity). During cardiogenesis plays an early role in cardiac contractility by promoting cardiac myofibril assembly (By similarity).
Classification
- Family (Pfam)
- PF13499 EF-hand_7
- InterPro
- EF-hand-dom_pair, EF_Hand_1_Ca_BS, EF_hand_dom, Myosin_RLC
- Functional cluster
- Ribosomal Protein L12 & Acyl Carriers
Experimental structures · PDB · 3
A predicted model is available from AlphaFold.
Gene Ontology · 22
- GO:0031672 A band
- GO:0097512 cardiac myofibril
- GO:0005737 cytoplasm
- GO:0005856 cytoskeleton
- GO:0005829 cytosol
- GO:0030016 myofibril
- GO:0016459 myosin complex
- GO:0030017 sarcomere
- GO:0003785 actin monomer binding
- GO:0005509 calcium ion binding
- GO:0032036 myosin heavy chain binding
- GO:0008307 structural constituent of muscle
- GO:0060048 cardiac muscle contraction
- GO:0055003 cardiac myofibril assembly
- GO:0060047 heart contraction
- GO:0007507 heart development
- GO:0042694 muscle cell fate specification
- GO:0030308 negative regulation of cell growth
- GO:0098735 positive regulation of the force of heart contraction
- GO:0006942 regulation of striated muscle contraction
- GO:0002026 regulation of the force of heart contraction
- GO:0055010 ventricular cardiac muscle tissue morphogenesis
Disease associations
- hypertrophic cardiomyopathy 10 MONDO:0012112
- myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy MONDO:0859168
Drugs targeting this protein · 3
- OMECAMTIV MECARBIL activator
- MAVACAMTEN inhibitor
- DANICAMTIV activator
Related proteins · sequence + function similarity
- Myosin regulatory light chain 2, ventricular/cardiac muscle isoform 0.99
- Myosin regulatory light chain 2, ventricular/cardiac muscle isoform 0.99
- Myosin regulatory light chain 2, ventricular/cardiac muscle isoform 0.99
- Myosin regulatory light chain 2, ventricular/cardiac muscle isoform 0.99
- Myosin regulatory light chain 2B, cardiac muscle isoform 0.98
- Myosin regulatory light chain 11 0.98
- Myosin regulatory light chain 11 0.98
- Myosin regulatory light chain 2A, cardiac muscle isoform 0.97
- Myosin regulatory light chain 11 0.97
- Myosin regulatory light chain 11 0.97
- Myosin regulatory light chain 2, skeletal muscle isoform 0.97
- Myosin regulatory light chain 2, skeletal muscle isoform type 1 0.97
Co-cited proteins · studied together in the literature
- Myosin regulatory light chain 2, ventricular/cardiac muscle isoform 2 shared papers
- Myosin light chain 3 3 shared papers
- Myocilin 1 shared papers
- Myosin-binding protein C, cardiac-type 2 shared papers
- Myosin-7 2 shared papers
- Fatty acid-binding protein, heart 1 shared papers
- Troponin T, cardiac muscle 2 shared papers
- Troponin I, cardiac muscle 1 shared papers
- Superoxide dismutase [Mn], mitochondrial 1 shared papers
- Cytochrome c oxidase subunit 5A, mitochondrial 1 shared papers
- Serotransferrin 1 shared papers
- ATP synthase F(1) complex subunit alpha, mitochondrial 1 shared papers
Literature · 15 cited papers
- Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy. PLoS Genet. · 2020
- Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy. Brain · 2013
- A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain. Mol. Cell. Proteomics · 2010
- Cardiac myosin is a substrate for zipper-interacting protein kinase (ZIPK). J. Biol. Chem. · 2010
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. · 2004
- Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J. Mol. Cell. Cardiol. · 2003
- Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation · 2003
- Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur. J. Hum. Genet. · 2002
- Protein interactions with myocilin. Invest. Ophthalmol. Vis. Sci. · 2002
- Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J. Biol. Chem. · 2001
- Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J. Mol. Med. · 1998
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. · 1996
- … and 3 more in the literature graph